The novel approach of this peptide represents a exciting development in the handling of the condition. Unlike existing therapies, tirzepatide affects two pathways – glucagon-like peptide-1 (GLP-1) and GIP – https://tirzepatide-peptide258607.blogs-service.com/73153328/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment